ANDREW M. OH
CIK 1746614 · Chief Financial Officer · last filed 2024-06-07
ANDREW M. OH is a Chief Financial Officer who has filed 6 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for SYRS, was dated Jun 7, 2024. Current disclosed insider exposure totals $6 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6
2
6
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRS | Director | 16,000 | $0.00 | $6 | $0 | 3 | 2024-06-07 |
| Rubius Therapeutics, Inc. (RUBY) Delisted | Chief Financial Officer | 5,000 | $0.08 | $415 | $0 | 3 | 2020-05-19 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-07 | SYRS | Grant (A) | +4,000 | $0 | EDGAR |
| 2023-06-02 | SYRS | Grant (A) | +4,000 | $0 | EDGAR |
| 2022-09-19 | SYRS | Grant (A) | +8,000 | $0 | EDGAR |
| 2020-05-19 | Rubius Therapeutics, Inc. (RUBY) Delisted | Exer (M) | +5,000 | $23.7K | EDGAR |
| 2020-02-03 | Rubius Therapeutics, Inc. (RUBY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-04 | Rubius Therapeutics, Inc. (RUBY) Delisted | Grant (A) | — | $0 | EDGAR |